Clinical Trials Logo

Clinical Trial Summary

Collect the details about hepatic dysfunctional patients induced by various etiology who have a usage of Glycyrrhizic Acid, then arrange and analyse the data to evaluate the clinical curative effect of glycyrrhizic acid.


Clinical Trial Description

This experiment will screen and collect qualified cases from medical records in Shuguang Hospital.to collect the patients with liver injury in clinic, including (1) conforms to ALT>1.5 times the normal value or >70 IU/L, age 18 to 70 years of age, sex is not limited; (2) patients with viral hepatitis or cirrhosis of the liver, or autoimmune liver disease, or schistosomiasis, or drug-induced liver damage, or for other reasons clear or unclear leading to abnormal liver function ; (3) except for tumor patients. The index of liver function such as ALT, AST, Alb, et al are detected respectively before and after preventive treatment of the glycyrrhizic acid for liver injury ,and through the synthesizing of the single sample difference t test and clinical practice to analyze the clinical efficacy of glycyrrhizin intervention treatment of hepatic injury ;


Study Design

Observational Model: Case-Only, Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT02329314
Study type Observational
Source ShuGuang Hospital
Contact Wu Chao, postgraduate
Phone 15221095202
Email 15221095202@163.com
Status Recruiting
Phase N/A
Start date November 2014
Completion date June 2016

See also
  Status Clinical Trial Phase
Completed NCT03795844 - COMPARISON OF LIVER RETRACTOR FOR INTRATOPERATIVE LIVER DAMAGE N/A
Recruiting NCT02769754 - Effectiveness of the Use of the New Hemostatic Patch Hemopatch ® in Patients Undergoing Surgical Liver Resection Phase 3
Completed NCT01274520 - Hypothermic Machine Preservation-Phase 2 N/A